Literature DB >> 6051335

Treatment of anthrax.

H Gold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6051335

Source DB:  PubMed          Journal:  Fed Proc        ISSN： 0014-9446


× No keyword cloud information.
  6 in total

1.  Beta-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain.

Authors:  Yahua Chen; Fred C Tenover; Theresa M Koehler
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 2.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Antimicrobial susceptibilities of diverse Bacillus anthracis isolates.

Authors:  Pamala R Coker; Kimothy L Smith; Martin E Hugh-Jones
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain.

Authors:  Yahua Chen; Janice Succi; Fred C Tenover; Theresa M Koehler
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

5.  An extracytoplasmic function sigma factor controls beta-lactamase gene expression in Bacillus anthracis and other Bacillus cereus group species.

Authors:  Cana L Ross; Kerrie S Thomason; Theresa M Koehler
Journal:  J Bacteriol       Date:  2009-08-28       Impact factor: 3.490

Review 6.  Bacillus anthracis as an agent of bioterrorism: a review emphasizing surgical treatment.

Authors:  Charles E Binkley; Sandro Cinti; Diane M Simeone; Lisa M Colletti
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.